Little is known about mental health (MH) emergencies in atopic dermatitis (AD) and their financial burden. We sought to determine hospitalization rates and costs of MH disorders in AD patients. We analyzed data from the Nationwide Inpatient Sample from 2002 to 2012, containing a representative 20% sample of US hospitalizations. Overall, 835 AD (1.36%) and 2,434,703 non-AD (0.75%) patients had a primary admission for an MH disorder. Atopic dermatitis patients admitted for MH disorders were more likely to be younger, Asian, of black race, and in a higher income quartile and have an increasing number of chronic conditions. In multivariable logistic regression models adjusting for demographics, AD was associated with a primary admission for MH disorders in adults, including mood disorders, schizophrenia, and developmental disorders. Atopic dermatitis was not associated with a primary admission for an MH disorder in children. There were an estimated US $183,821,629 excess costs of care annually for MH disorders in inpatients with versus without AD. In conclusion, AD was associated with higher odds of hospitalization for all MH disorders and substantial excess costs of inpatient care.
METHODS
We analyzed data from the 2002-2012 Nationwide Inpatient Sample (NIS) provided by the Healthcare Cost and Utilization Project (HCUP) from the Agency for Healthcare Research and Quality (AHRQ). Each year of NIS contains an approximately 20% stratified representative sample of all inpatient hospitalizations in the United States. Sample weights were created by the NIS that factored the complex sampling design of US hospitals and allowed for representative estimates of discharges across the whole country. All data were deidentified, and no attempts were made to identify any of the individuals in the database. All parties with access to the HCUP were compliant to HCUP's formal data use agreement. The study was approved by the institutional review board of the Northwestern University.
Identification of AD and MH Disorders
The NIS lists only 1 primary diagnosis and up to 24 secondary diagnoses. Per HCUP inpatient database standards, the first listed diagnosis is the principal diagnosis, that is, the primary reason for hospitalization. The databases were searched for primary and secondary diagnoses of AD using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 691.8. Primary and secondary diagnoses of AD were coded separately. We previously found the code 691.8 to be sufficiently valid to identify AD in the inpatient setting. 14 The control group included all patients without any diagnosis of AD, excluding live births and normal pregnancies, yielding a representative cohort of hospitalized patients in the United States.
Mental health comorbidities were precoded according to the AHRQ comorbidity measures and through the NIS Clinical Classification Software. Comorbidities precoded by the AHRQ also used diagnosis-related groups and thus would capture a higher frequency of the comorbidities in comparison with the use of ICD-9-CM codes alone. Admission for an MH emergency was identified by a primary diagnosis of the disorder. An MH comorbidity was considered present with a secondary diagnosis of the disorder. The MH disorders included mood disorders (including bipolar disorder and depression), anxiety, suicidality, substance abuse, cognitive, developmental, adjustment, impulse, personality, pediatric and other MH disorders, and alcohol abuse. A variety of ICD-9-CM codes for MH disorders, including those for alcohol abuse, depression, 15 schizophrenia, 16 suicide attempt, substance abuse, 17 psychosis, bipolar disorder, and affective disorders, 18 have been found to have a strong positive predictive value for the use in epidemiological studies The codes used to create these variables are presented in the Supplemental Table ( http://links.lww.com/DER/A17). A composite variable was created for any MH disorder.
Statistics
All data were processed using SAS 9.4 (SAS Institute, Cary, NC). Baseline characteristics of patient subsets were determined. Complete case analysis was performed. A 2-sided P value of less than 0.05 was taken to indicate statistical significance for all estimates. The prevalence of having a primary or secondary MH disorder was determined in children and/or adults with or without AD. Results were stratified by sex (male/female), race (white/black/Hispanic/ other), having insurance (yes/no), and age (by decade). To examine the associations of AD with any MH comorbidities as well as with a primary admission for MH emergencies, multivariable logistic regression models adjusting for age, sex, and race/ethnicity were constructed with any diagnosis or a primary diagnosis of each of the MH comorbidities as the dependent variables, respectively. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated. Post hoc correction for multiple dependent tests was performed by minimizing the false discovery rate with the approach of Benjamini and Hochberg, 19 and corrected P values are presented. Adjusted odds ratio and 95% CI were presented in forest plots using OpenMeta Analyst, an open-source software supported by Brown University and the AHRQ. Summary statistics were determined for LOS and cost of inpatient care, including total and geometric mean (95% CI). To determine the predictors of hospitalization, survey-weighted multivariable logistic regression models were constructed with hospitalization for MH disorders as the dependent variable and AD as the independent variable. To determine the predictors of cost of care and LOS, multivariable linear regression models were constructed with log-transformed cost of care and LOS as the dependent variables. Cost of care and LOS were log transformed because they were not normally distributed. Other independent variables included age (0-4/5-10/11-17/18-39/ 40-59/60-79/≥80 years), sex (male/female), race/ethnicity (white/ black/Hispanic/Asian/Native American/other), mean annual income of the hospital zip code (quartiles), health insurance coverage (yes/ no; Medicare/Medicaid/private/self-pay/no charge/other), number of chronic conditions (0-1/2-5/≥6), season of admission (winter/spring/ summer/autumn), hospital location (metropolitan/fringe-metropolitan/ micropolitan/not metropolitan or micropolitan; northeast/ midwest/south/west), and admission year. Multivariable logistic regression models used stepwise selection from the previously mentioned covariates (α < .1). 
RESULTS

Overall
Association of Demographics With AD Patients
In multivariable logistic regression models adjusting for demographics, decreasing age (aOR [ (Fig. 1) . Atopic dermatitis was associated with a primary admission for MH disorders, including mood disorders, schizophrenia, and developmental disorders. Atopic dermatitis was not associated with a primary admission for an MH disorder in children overall or for specific MH disorders.
Association of AD and Any MH Disorders
In multivariable logistic regression models, AD was associated with any (primary or secondary) diagnosis of MH disorders (130 [1.25-1.36]) (Fig. 2) . Among both adults and children, AD was associated with anxiety disorders and developmental disorders. However, AD was only associated with mood disorders, schizophrenia, cognitive disorders, suicide or self-inflicted injury, alcohol abuse, substance abuse, personality disorders, adjustment disorders, attention deficit disorder/attention deficit hyperactivity disorder (ADD/ADHD), or conduct disorders in adults, but not children.
Cost of Care and LOS
The geometric mean cost of inpatient care for any MH was significantly higher in patients with versus without AD (US $12,112 vs $4504, respectively; P < 0.0001) ( Table 3) . Geometric mean cost of hospitalization was greater for patients with versus without AD admitted for schizophrenia, mood disorders, personality disorders, substance-related disorders, disorders diagnosed in childhood, alcohol use disorder, cognitive disorders, impulse control disorders, ADD/ADHD, and miscellaneous MH disorders. There were an estimated US $183,821,629 excess costs of hospital care annually for MH disorders in patients with versus without AD, with mood disorders, delirium/cognitive disorders, and anxiety disorders accounting for the most excess costs associated with MH disorders. For patients admitted primarily for an MH disorder with AD as a comorbidity, increased cost of care was associated with Asian and other race/ethnicity and hospital location in micropolitan area (linear regression, P < 0.05 for all) ( Table 3) .
The geometric mean LOS was significantly higher in patients with AD (15.51 days) versus those without AD (8.32; P < 0.0001) for hospitalization for any MH disorder. The geometric mean LOS was greater for patients with AD versus those without AD for schizophrenia, mood disorders, personality disorders, alcohol use disorder, cognitive disorders, impulse control disorders, and other MH disorders. There were an estimated 288,520 excess days of hospitalization annually for MH disorders in patients with versus without AD, with mood disorders, delirium/cognitive disorders, and anxiety disorders accounting for the most excess LOS associated with MH disorders. For patients admitted primarily for an MH disorder with AD as a comorbidity, increased LOS was not associated with any demographic factors.
Impact of AD on Inpatient Mortality
Patients who were admitted primarily for an MH disorder had similar inpatient mortality in those with versus without AD ( Table 4) .
None of the MH disorders demonstrated higher rates of mortality in AD patients.
DISCUSSION
The present study found strong associations between AD and numerous MH disorders in both children and adults. In particular, AD was associated with higher odds of primary admission for multiple MH disorders, including mood disorders, schizophrenia, and developmental disorders. Associations of MH disorders among Figure 1 . Association between primary admission for MH disorders and AD. Survey logistic regression models were constructed with MH disorders as the independent variable and AD as the dependent variable. Odds ratios and 95% CIs were estimated. Multivariate models included race/ethnicity, age, and sex as covariates. Adjusted odds ratios and 95% CIs were estimated. Forest plots of the aORs and 95% CIs are presented.
AD patients were younger age, nonwhite race/ethnicity, increasing number of chronic conditions, and higher household income. Atopic dermatitis was associated with increased LOS and cost of hospitalization for any MH disorder and when examined individually. However, AD was not associated with increased inpatient mortality among those admitted primarily for an MH disorder. Taken together, the results of this study indicate that AD is associated with substantially increased morbidity from MH disorders, but not inpatient mortality. Moreover, AD was associated with an excess US $180 million cost of hospitalization for an MH comorbidity. This study expands on previous studies that demonstrated significantly higher rates of MH disorders in persons with versus without AD. 7, 8, 20, 21 A US population-based survey (National Survey of Children's Health) found that children with versus without AD had significantly higher prevalences of depression, anxiety, oppositional defiant, and conduct disorders. 8 Two US population-based surveys found that approximately 1 in 5 adults with AD met sleep changes, interest loss, guilt, energy decrease, concentration deficit, appetite loss, psychomotor agitation or retardation, suicidality criteria for major depressive disorder (National Health and Nutrition Examination Survey) or were diagnosed by a health care provider with depression (National Health Interview Survey); the odds of depression were significantly higher in those with versus without AD even after controlling for multiple potential confounders. 7 Previous studies also Figure 2 . Association between any diagnosis of an MH disorder and AD. Survey logistic regression models were constructed with MH disorders as the independent variable and AD as the dependent variable. Odds ratios and 95% CIs were estimated. Multivariate models included race/ethnicity, age, and sex as covariates. Adjusted odds ratios and 95% CIs were estimated. Forest plots of the aORs and 95% CIs are presented.
found higher incidence of major depressive disorder in Taiwanese adolescents/adults (1.42 vs 0.20 per 1000 person-years) 20 and higher prevalence of depression in male Koreans with versus without AD (10.4% vs 5.3%). 21 A previous study from the Danish national health registries found higher rates of depression, anxiety, and suicidal ideation in the general population and increased use of antidepressant and anxiolytic medications particularly among patients with moderate-severe AD but no increased risk of hospitalization for depression, anxiety, or suicidality. 22 In contrast, we found significantly higher odds of hospitalization primarily for all MH disorders among those with versus without AD. The higher rates of hospitalization for MH disorders observed in the United States, but not Denmark, may be related to racial/ethnic disparities. This is supported by the association of MH admissions among AD patients who were nonwhite. However, there are likely other factors that contribute to increased hospitalization for MH disorders in AD.
The finding that AD is associated with significantly higher rates of multiple MH disorders has several clinical ramifications. Atopic dermatitis patients should be screened for MH symptoms in the primary care, allergy, and/or dermatology setting and treated with or referred for appropriate psychiatric care. Atopic dermatitis patients with comorbid MH symptoms may warrant pharmacologic and/or psychotherapeutic management of their MH disorders. The optimal management approaches for such patients have not been studied. They may also warrant earlier, more aggressive topical and/or systemic treatments of their AD. However, it is yet unknown whether more aggressive management of AD can mitigate the higher rates of MH disorders or lower the associated morbidity of AD while being hospitalized for an MH disorder.
The relationship between AD and MH is likely bidirectional. Atopic dermatitis may directly cause or exacerbate MH symptoms, for example, depression, anxiety, and inattentiveness, secondary to chronic and bothersome itch, pain, sleep deprivation, self-consciousness, and social isolation. [23] [24] [25] Many of these MH symptoms may be reversible with optimized management of patients' cutaneous disease, although stress and MH comorbidity may trigger AD. 26 Worsening of skin disease by emotional factors is one of the minor diagnostic criteria of AD from Hanifin and Rajka. 27 Given the cross-sectional nature of the study, we were unable to assess the direction of association between AD and MH disorders. Previous studies speculated multiple mechanisms by which AD upregulates neuroimmune factors, for example, brain-derived neurotrophic factor, 28 neuropeptide-induced sensitivity, 29 and inflammatory cytokines, resulting in heightened sensitivity to stimuli, 30, 31 poor sleep, and the subsequent development of MH disorders. 32, 33 Sleep disturbance in AD might be related to chronic itch, inflammation, 34, 35 and degree of atopy. 36 In turn, these sleep disturbances may unmask other psychiatric symptoms. Another potential contributor to MH disorders in AD patients is the use of systemic corticosteroids for moderatesevere diseases, which have been shown to cause multiple MH symptoms. [37] [38] [39] Unfortunately, we were not able to assess the use of systemic corticosteroids and other medication history, because these were not recorded in the NIS database. The mechanisms of relationship between AD, sleep disturbance, and MH disorders warrant further study. Strengths of this study include an analysis of a nationally representative sample of all-payer data for a period of 11 years with more than 70 million records. Limitations of this study include the inability to perform a temporal analysis of comorbidities, because date of diagnosis was not present. We were unable to assess the medications used before, during, or after admission. Identification of comorbid health conditions was performed using ICD-9-CM and diagnosisrelated group codes and not by review of the health record. Some MH disorders can lead to impaired self-care and nutritional disorders with associated cutaneous eruptions, which may be misclassified as AD. The NIS lacks the ability to classify patients by the severity of the AD. Finally, because there were no patient identifiers, patient rehospitalization could not be identified.
In conclusion, AD was associated with a considerable MH burden, especially among adults, with higher prevalence of MH disorders, overall, and primary admissions, in particular, as well as increased LOS and cost of hospitalization for MH disorders, although without any substantial mortality. Future studies are needed to determine the optimal management approaches for their AD and MH diseases. 
